advanced gastric cancer

Showing 1 - 25 of 61

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HER2-overexpressed Advanced Solid Tumors After Progression of

Not yet recruiting
  • HER2
  • +3 more
  • Disitamab Vedotin
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Dec 14, 2022

Advanced Gastric Cancer Trial in Seoul (Intergrate early palliatuve care + Conventional chemo, Conventional chemo)

Recruiting
  • Advanced Gastric Cancer
  • Intergrate early palliatuve care + Conventional chemotherapy
  • Conventional chemotherapy
  • Seoul, Korea, Republic of
    Yonsei Cancer Center, Yonsei University College of Medicine
Oct 17, 2022

Advanced Gastric Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Relatlimab)

Active, not recruiting
  • Advanced Gastric Cancer
  • Nivolumab
  • +4 more
  • Phoenix, Arizona
  • +34 more
Aug 18, 2022

Advanced Gastric Cancer Trial in China (fruquintinib +paclitaxel, fruquintinib + paclitaxel)

Active, not recruiting
  • Advanced Gastric Cancer
  • fruquintinib +paclitaxel
  • fruquintinib placebo + paclitaxel
  • Hefei, Anhui, China
  • +6 more
Aug 16, 2022

Advanced Solid Tumor, Advanced Breast Cancer, Advanced Gastric Cancer Trial in Boston, Dallas, Fairfax (IMM2902)

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jul 21, 2022

Advanced Gastric Cancer Trial in Shanghai (Transcatheter Arterial Chemoembolization, Tislelizumab)

Recruiting
  • Advanced Gastric Cancer
  • Shanghai, Shanghai, China
    ZhongShan hospital Fudan university
May 25, 2022

Advanced Hepatocellular Carcinoma, Advanced Colorectal Cancer, Advanced Gastric Cancer Trial in Hangzhou (EPCAM CAR-T)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • +3 more
  • EPCAM CAR-T
  • Hangzhou, China
    First affiliated hospital, School of Medicine, Zhejiang Universi
Jan 12, 2022

Advanced Gastric Cancer Trial in Seoul (Paclitaxel, Olaparib, Durvalumab)

Active, not recruiting
  • Advanced Gastric Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 22, 2021

Advanced Gastric Cancer, Advanced Gastroesophageal Junction Adenocarcinoma Trial in Wuhan (PD-1 inhibitor(Tislelizumab)

Recruiting
  • Advanced Gastric Cancer
  • Advanced Gastroesophageal Junction Adenocarcinoma
  • PD-1 inhibitor(Tislelizumab) ,SOX(S-1+ Oxaliplatin)
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College of HUST
Aug 4, 2021

Advanced Gastric Cancer, Peritoneal Carcinomatosis Trial in Seoul (1. Treatment: IP chemo + Systemic chemo, 2. Response

Recruiting
  • Advanced Gastric Cancer
  • Peritoneal Carcinomatosis
  • 1. Treatment: IP chemotherapy + Systemic chemotherapy
  • 2. Response evaluation after 4 cycles of IP + systemic chemotherapy
  • Seoul, Gangnnam, Korea, Republic of
    Gangnam Severacne Hospital
Mar 11, 2021

Advanced Gastric Cancer, Gastro-esophageal Junction Cancer Trial in Worldwide (AUY922, Docetaxel, Irinotecan)

Completed
  • Advanced Gastric Cancer
  • Gastro-esophageal Junction Cancer
  • Los Angeles, California
  • +35 more
Dec 8, 2020

Advanced Gastric Cancer Trial in Worldwide (AUY922, Trastuzumab)

Terminated
  • Advanced Gastric Cancer
  • Los Angeles, California
  • +14 more
Dec 8, 2020

Advanced Gastric Cancer Trial in Guangzhou (Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Gastric cancer,

Withdrawn
  • Advanced Gastric Cancer
  • Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Gastric cancer
  • Cryotherapy
  • Guangzhou, Guangdong, China
    Institutional Review Board of Guangzhou Fuda Cancer Hospital
Oct 13, 2020

Advanced Gastric Cancer Trial in Fuzhou (Camrelizumab, Apatinib Mesylate, nab-paclitaxel)

Recruiting
  • Advanced Gastric Cancer
  • Fuzhou, Fujian, China
    Fujian Medical University Union Hospital
Jun 3, 2020

Advanced Gastric Cancer, Gastroesophageal Cancer Trial in Zibo (Cell infusion for Dose-finding (Group A), Cell infusion for

Recruiting
  • Advanced Gastric Cancer
  • Gastroesophageal Cancer
  • Cell infusion for Dose-finding (Group A)
  • Cell infusion for Extended research (Group B)
  • Zibo, China
    Changguo hospital of Zibo
May 9, 2020

Advanced Gastric Cancer Trial in Shenyang (Albumin-paclitaxel, Apatinib, Camrelizumab)

Unknown status
  • Advanced Gastric Cancer
  • Albumin-paclitaxel, Apatinib, Camrelizumab
  • Shenyang, Liaoning, China
    The First Hospital of China Medical University
Feb 25, 2020

Advanced Gastric Cancer, Esophagogastric Junction Cancer Trial in Frankfurt/Main (Paclitaxel, RAD001)

Completed
  • Advanced Gastric Cancer
  • Esophagogastric Junction Cancer
  • Frankfurt/Main, Germany
    Krankenhaus Nordwest
Jan 27, 2020

Advanced Gastric Cancer Trial in Seoul (Capecitabine, Cisplatin, Sorafenib)

Completed
  • Advanced Gastric Cancer
  • Capecitabine, Cisplatin, Sorafenib
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 6, 2020

Advanced Gastric Cancer Trial in Seoul (RAD001, Capecitabine, Oxaliplatin)

Completed
  • Advanced Gastric Cancer
  • RAD001, Capecitabine, Oxaliplatin
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Jan 6, 2020

Advanced Gastric Cancer Trial in Seoul (Docetaxel, Capecitabine, Cisplatin, Bevacizumab)

Completed
  • Advanced Gastric Cancer
  • Docetaxel, Capecitabine, Cisplatin, Bevacizumab
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 6, 2020

Venous Thromboembolism in Advanced Gastric Cancer Patients

Completed
  • Advanced Gastric Cancer
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Jan 6, 2020

    Advanced Gastric Cancer Trial in Seoul (S-1 and cisplatin)

    Completed
    • Advanced Gastric Cancer
    • S-1 and cisplatin
    • Seoul, Korea, Republic of
      Department of Oncology, Asan Medical Center
    Jan 6, 2020

    Advanced Gastric Cancer Trial in Seoul (oxaliplatin, 5-fluorouracil)

    Completed
    • Advanced Gastric Cancer
    • oxaliplatin, 5-fluorouracil
    • Seoul, Korea, Republic of
      Asan medical center
    Jan 6, 2020

    Advanced Gastric Cancer Trial in Seoul (AZD5363, paclitaxel)

    Completed
    • Advanced Gastric Cancer
    • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
      Samsung Medical Center
    Dec 26, 2019